Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentSOSS complex

NABP1 NABP2

1.19e-054302GO:0070876
GeneOntologyCellularComponentextrinsic component of plasma membrane

DCHS1 ANK2 TIAM1 DTNA

4.24e-05137304GO:0019897
GeneOntologyCellularComponentextrinsic component of membrane

DCHS1 ANK2 TIAM1 DTNA

3.13e-04230304GO:0019898
DomainNA-bd_OB_tRNA

NABP1 NABP2

1.63e-0412302IPR004365
DomaintRNA_anti-codon

NABP1 NABP2

1.63e-0412302PF01336
DomainGDS_CDC24_CS

TIAM1 ARHGEF10

1.78e-0339302IPR001331
DomainHMG_box

TOX TOX2

3.27e-0353302PF00505
DomainHMG_BOX_2

TOX TOX2

3.39e-0354302PS50118
DomainHMG

TOX TOX2

3.39e-0354302SM00398
Domain-

TOX TOX2

3.51e-03553021.10.30.10
DomainDH_1

TIAM1 ARHGEF10

4.58e-0363302PS00741
DomainHMG_box_dom

TOX TOX2

4.87e-0365302IPR009071
DomainRhoGEF

TIAM1 ARHGEF10

5.32e-0368302SM00325
DomainDH_2

TIAM1 ARHGEF10

5.63e-0370302PS50010
DomainRhoGEF

TIAM1 ARHGEF10

5.63e-0370302PF00621
DomainDH-domain

TIAM1 ARHGEF10

5.79e-0371302IPR000219
Domain-

TIAM1 ARHGEF10

5.79e-03713021.20.900.10
DomainNA-bd_OB-fold

NABP1 NABP2

7.83e-0383302IPR012340
DomainWD40_repeat_dom

STRN ARHGEF10 BRWD3

1.18e-02297303IPR017986
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SORBS1 ANK2 PRPF8 TIAM1 ARHGEF10 DSCAML1 BRWD3 RBCK1 NABP2 BACH1

7.00e-081285301035914814
Pubmed

CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction.

CD44 FGFR2

7.19e-07230236463112
Pubmed

CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.

CD44 EPAS1

7.19e-07230228813675
Pubmed

NABP1, a novel RORgamma-regulated gene encoding a single-stranded nucleic-acid-binding protein.

NABP1 NABP2

7.19e-07230216533169
Pubmed

BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression.

CD44 BACH1

7.19e-07230234949193
Pubmed

Characterization of the effects of cross-linking of macrophage CD44 associated with increased phagocytosis of apoptotic PMN.

CD44 TIAM1

7.19e-07230222427969
Pubmed

CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma.

TOX TOX2

7.19e-07230235111387
Pubmed

CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.

CD44 TIAM1

7.19e-07230210636882
Pubmed

A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.

CD44 FGFR2

2.16e-06330227107424
Pubmed

Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.

TOX TOX2

4.31e-06430222496870
Pubmed

Heme induces ubiquitination and degradation of the transcription factor Bach1.

RBCK1 BACH1

4.31e-06430217682061
Pubmed

The PHCCEx domain of Tiam1/2 is a novel protein- and membrane-binding module.

CD44 TIAM1

4.31e-06430219893486
Pubmed

Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

NABP1 NABP2

7.18e-06530228270450
Pubmed

Single strand DNA binding proteins 1 and 2 protect newly replicated telomeres.

NABP1 NABP2

1.08e-05630223459151
Pubmed

HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response.

NABP1 NABP2

1.08e-05630219605351
Pubmed

SSB1/SSB2 Proteins Safeguard B Cell Development by Protecting the Genomes of B Cell Precursors.

NABP1 NABP2

1.08e-05630231085591
Pubmed

Single-stranded DNA-binding protein hSSB1 is critical for genomic stability.

NABP1 NABP2

1.51e-05730218449195
Pubmed

Transcriptomic analysis of PNN- and ESRP1-regulated alternative pre-mRNA splicing in human corneal epithelial cells.

CD44 FGFR2

1.51e-05730223299472
Pubmed

CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin.

CD44 TIAM1

1.51e-05730217702746
Pubmed

A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

SORBS1 ANK2 DTNA

1.92e-056030319075228
Pubmed

SOSS complexes participate in the maintenance of genomic stability.

NABP1 NABP2

2.01e-05830219683501
Pubmed

The hSSB1 orthologue Obfc2b is essential for skeletogenesis but dispensable for the DNA damage response in vivo.

NABP1 NABP2

3.22e-051030222940690
Pubmed

KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin.

CD44 FGFR2

3.94e-051130219474150
Pubmed

Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.

STRN SORBS1 NDUFV2

5.26e-058430319165527
Pubmed

Cell-type-specific consequences of Reelin deficiency in the mouse neocortex, hippocampus, and amygdala.

NDNF COL5A1 TOX

6.05e-058830321491433
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

SORBS1 TRANK1 UTP3 PRPF8 BACH1

6.20e-0549730536774506
Pubmed

The apical ectodermal ridge is a timer for generating distal limb progenitors.

CD44 FGFR2

7.50e-051530218359901
Pubmed

Genetic rescue of Muenke syndrome model hearing loss reveals prolonged FGF-dependent plasticity in cochlear supporting cell fates.

CD44 FGFR2

8.57e-051630224145799
Pubmed

Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2.

NABP1 NABP2

9.70e-051730223408915
Pubmed

Integrator3, a partner of single-stranded DNA-binding protein 1, participates in the DNA damage response.

NABP1 NABP2

9.70e-051730219759019
Pubmed

LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans.

CD44 TIAM1

1.22e-041930225956904
Pubmed

An Alternative Splicing Program for Mouse Craniofacial Development.

CD44 SORBS1

1.50e-042130233013468
Pubmed

Hypoxia inducible factor 3α plays a critical role in alveolarization and distal epithelial cell differentiation during mouse lung development.

FGFR2 EPAS1

1.80e-042330223451260
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

SORBS1 RESF1 DSCAML1

1.92e-0413030312421765
Pubmed

Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool.

DCHS1 FGFR2

1.96e-042430226116661
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

ANK2 PRPF8 TIAM1 ARHGEF10 DTNA NDUFV2 BACH1

2.20e-04148730733957083
Pubmed

Inactivation of Zeb1 in GRHL2-deficient mouse embryos rescues mid-gestation viability and secondary palate closure.

CD44 FGFR2

2.68e-042830232005677
Pubmed

Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.

COL5A1 PLEKHH2 ANK2 PRPF8

2.80e-0437130415747579
Pubmed

Fgf10 is required for specification of non-sensory regions of the cochlear epithelium.

CD44 FGFR2

2.88e-042930225624266
Pubmed

The placental vasculature is affected by changes in gene expression and glycogen-rich cells in a diet-induced obesity mouse model.

EPAS1 BACH1

2.88e-042930237948457
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

STRN SORBS1 ANK2 DTNA NDUFV2 BACH1

3.68e-04113930636417873
Pubmed

Integrated Transcriptome and Network Analysis Reveals Spatiotemporal Dynamics of Calvarial Suturogenesis.

COL5A1 FGFR2

3.74e-043330232640236
Pubmed

Single-cell transcriptomic analysis of mouse neocortical development.

CD44 NDNF EPAS1

4.23e-0417030330635555
Pubmed

Gonadal sex reversal in mutant Dax1 XY mice: a failure to upregulate Sox9 in pre-Sertoli cells.

FGFR2 DTNA

4.45e-043630215944188
Pubmed

Networks of bZIP protein-protein interactions diversified over a billion years of evolution.

EPAS1 BACH1

5.50e-044030223661758
Pubmed

ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative Splicing that Disrupt Cochlear Development.

CD44 FGFR2

6.06e-044230229107558
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

SORBS1 RESF1 TIAM1 ARHGEF10 BACH1

7.83e-0486130536931259
InteractionCTDSPL interactions

CD44 FGFR2 TIAM1 DTNA

1.02e-0592304int:CTDSPL
Cytoband21q22.11

TIAM1 BACH1

7.62e-046230221q22.11
CytobandEnsembl 112 genes in cytogenetic band chr2p21

PLEKHH2 EPAS1

1.26e-0380302chr2p21
CoexpressionLIU_PROSTATE_CANCER_DN

NDNF COL5A1 SORBS1 FGFR2 PLEKHH2 ANK2 DTNA EPAS1 ACOX2

2.76e-09493309M19391
CoexpressionGSE40443_INDUCED_VS_TOTAL_TREG_UP

NABP1 TOX TIAM1 TOX2 BACH1

2.93e-06199305M9198
CoexpressionGAVIN_FOXP3_TARGETS_CLUSTER_T4

CD44 RESF1 TIAM1 SYNGR2

4.49e-0697304M1729
CoexpressionGAVIN_FOXP3_TARGETS_CLUSTER_T4

CD44 RESF1 TIAM1 SYNGR2

5.06e-06100304MM1215
CoexpressionLIM_MAMMARY_STEM_CELL_UP

DCHS1 COL5A1 SORBS1 TOX EPAS1 BACH1

1.48e-05479306M2573
CoexpressionLIM_MAMMARY_STEM_CELL_UP

DCHS1 COL5A1 SORBS1 TOX EPAS1 BACH1

1.55e-05483306MM1082
CoexpressionGOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION

SORBS1 DSCAML1 BRWD3

1.62e-0543303MM926
CoexpressionGOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION

SORBS1 DSCAML1 BRWD3

1.62e-0543303M2370
CoexpressionZHENG_BOUND_BY_FOXP3

CD44 UTP3 TOX ARHGEF10 IFT57 NDUFV2

1.84e-05498306M1741
CoexpressionZHENG_BOUND_BY_FOXP3

CD44 UTP3 TOX ARHGEF10 IFT57 NDUFV2

2.03e-05507306MM1030
CoexpressionASTON_MAJOR_DEPRESSIVE_DISORDER_DN

FGFR2 TIAM1 ARHGEF10 SYNGR2

3.24e-05160304M11011
CoexpressionKIM_GERMINAL_CENTER_T_HELPER_UP

UTP3 RESF1 TOX

5.38e-0564303M1405
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL

SORBS1 TRANK1 DTNA SYNGR2

6.20e-05189304M45678
CoexpressionGSE25087_TREG_VS_TCONV_FETUS_UP

NABP1 TOX TOX2 EPAS1

7.42e-05198304M4647
CoexpressionGSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN

TRANK1 RBCK1 NDUFV2 BACH1

7.42e-05198304M3267
CoexpressionJOHNSTONE_PARVB_TARGETS_3_UP

PRPF8 TOX2 EPAS1 SYNGR2 RBCK1

1.22e-04433305M2240
CoexpressionSENESE_HDAC1_TARGETS_UP

CD44 STRN NABP1 RESF1 BACH1

1.47e-04451305M14973
CoexpressionCHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN

CD44 COL5A1 TOX TOX2 BACH1

1.70e-04465305M9192
CoexpressionKANG_AR_TARGETS_UP

COL5A1 FGFR2

1.70e-0417302MM1297
CoexpressionKANG_AR_TARGETS_UP

COL5A1 FGFR2

1.70e-0417302M2223
CoexpressionBOQUEST_STEM_CELL_UP

CD44 COL5A1 ANK2 ACOX2

2.15e-04261304M1834
CoexpressionSENESE_HDAC3_TARGETS_UP

CD44 STRN PLEKHH2 ACOX2 BACH1

2.27e-04495305M8451
CoexpressionMALTA_CURATED_STEMNESS_MARKERS

CD44 EPAS1

2.62e-0421302M30411
CoexpressionGAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS

NDNF COL5A1 NABP1

2.91e-04113303M43610
CoexpressionBENPORATH_OCT4_TARGETS

SORBS1 FGFR2 RESF1 DTNA

3.21e-04290304M17183
CoexpressionCHANDRAN_METASTASIS_DN

NDNF SORBS1 FGFR2 ARHGEF10

4.44e-04316304M11615
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HRGL3

CD44 NDNF PLEKHH2 IFT57 DTNA

4.48e-04574305M39056
CoexpressionMARTINEZ_RB1_AND_TP53_TARGETS_UP

CD44 SORBS1 FGFR2 NABP1 EPAS1

6.50e-04623305M15896
CoexpressionBENPORATH_NANOG_TARGETS

STRN SORBS1 FGFR2 RESF1 TIAM1 DTNA

7.72e-04988306M6616
CoexpressionGSE13547_WT_VS_ZFX_KO_BCELL_UP

STRN TOX TOX2

8.47e-04163303M2997
CoexpressionTRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL

CD44 NABP1 PLEKHH2

8.62e-04164303M41676
CoexpressionHUANG_FOXA2_TARGETS_DN

CD44 ACOX2

8.68e-0438302M16701
CoexpressionBURTON_ADIPOGENESIS_PEAK_AT_8HR

CD44 TIAM1

9.14e-0439302M1641
CoexpressionHU_FETAL_RETINA_FIBROBLAST

NDNF COL5A1 FGFR2 PLEKHH2

9.28e-04385304M39264
CoexpressionMARTINEZ_RB1_AND_TP53_TARGETS_UP

CD44 SORBS1 FGFR2 NABP1 EPAS1

1.02e-03689305MM1041
CoexpressionGSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP

CD44 STRN SYNGR2

1.02e-03174303M333
CoexpressionMARTINEZ_RB1_TARGETS_UP

CD44 SORBS1 FGFR2 NABP1 BACH1

1.03e-03690305M12224
CoexpressionBURTON_ADIPOGENESIS_PEAK_AT_8HR

CD44 TIAM1

1.06e-0342302MM691
CoexpressionBENPORATH_NOS_TARGETS

FGFR2 RESF1 DTNA

1.11e-03179303M14573
CoexpressionKHETCHOUMIAN_TRIM24_TARGETS_UP

CD44 FGFR2

1.27e-0346302MM544
CoexpressionTRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL

CD44 NABP1 EPAS1 NDUFV2 BACH1

1.27e-03724305M41700
CoexpressionSWEET_LUNG_CANCER_KRAS_DN

SORBS1 FGFR2 TIAM1 EPAS1

1.30e-03422304M7396
CoexpressionKHETCHOUMIAN_TRIM24_TARGETS_UP

CD44 FGFR2

1.33e-0347302M1399
CoexpressionHAN_SATB1_TARGETS_UP

TOX EPAS1 RBCK1 NDUFV2

1.34e-03425304M9639
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

NDNF STRN SORBS1 FGFR2 DTNA DSCAML1

1.36e-031102306M2369
CoexpressionGSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP

CD44 RESF1 BACH1

1.40e-03194303M7313
CoexpressionGSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP

PRPF8 RBCK1 NABP2

1.40e-03194303M6103
CoexpressionMARTINEZ_RB1_TARGETS_UP

CD44 SORBS1 FGFR2 NABP1 BACH1

1.41e-03741305MM1037
CoexpressionGSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP

CD44 IFT57 ZNF768

1.42e-03195303M7926
CoexpressionGSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP

COL5A1 ZNF768 ACOX2

1.42e-03195303M6899
CoexpressionGSE29618_BCELL_VS_PDC_UP

RESF1 IFT57 BACH1

1.44e-03196303M4940
CoexpressionGSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP

PRPF8 ARHGEF10 EPAS1

1.46e-03197303M4993
CoexpressionGSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP

PRPF8 SYNGR2 NABP2

1.48e-03198303M7046
CoexpressionGSE3982_BASOPHIL_VS_NKCELL_UP

UTP3 NDUFV2 BACH1

1.48e-03198303M5561
CoexpressionGSE3982_MAC_VS_BASOPHIL_DN

TRANK1 RESF1 BACH1

1.48e-03198303M5498
CoexpressionGSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP

DCHS1 NDNF IFT57

1.48e-03198303M8866
CoexpressionKENNY_CTNNB1_TARGETS_UP

SORBS1 NABP1

1.50e-0350302M11067
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

NDNF STRN SORBS1 FGFR2 DTNA DSCAML1

1.50e-031124306MM1070
CoexpressionGSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN

TRANK1 TOX RBCK1

1.50e-03199303M4635
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP

NABP1 ARHGEF10 BACH1

1.50e-03199303M7712
CoexpressionGSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN

TRANK1 RBCK1 NDUFV2

1.50e-03199303M7645
CoexpressionGSE29949_MICROGLIA_VS_DC_BRAIN_UP

CD44 ANK2 TIAM1

1.50e-03199303M8399
CoexpressionMCBRYAN_PUBERTAL_BREAST_6_7WK_UP

SORBS1 RESF1 EPAS1

1.50e-03199303MM991
CoexpressionHALLMARK_IL2_STAT5_SIGNALING

CD44 TIAM1 SYNGR2

1.50e-03199303M5947
CoexpressionGSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN

CD44 UTP3 NDUFV2

1.50e-03199303M9943
CoexpressionMCBRYAN_PUBERTAL_BREAST_6_7WK_UP

SORBS1 RESF1 EPAS1

1.50e-03199303M2155
CoexpressionGSE3982_MAST_CELL_VS_NKCELL_UP

SORBS1 UTP3 EPAS1

1.50e-03199303M5450
CoexpressionGSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP

DCHS1 NABP1 SYNGR2

1.50e-03199303M9252
CoexpressionGSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN

TOX TOX2 IFT57

1.50e-03199303M9288
CoexpressionGSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN

NDNF RESF1 EPAS1

1.50e-03199303M9283
CoexpressionGSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN

CD44 NABP1 TIAM1

1.50e-03199303M7463
CoexpressionGSE31082_DN_VS_DP_THYMOCYTE_DN

STRN BRWD3 BACH1

1.53e-03200303M5055
CoexpressionGSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN

TOX BRWD3 BACH1

1.53e-03200303M5073
CoexpressionGSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP

RESF1 TIAM1 NDUFV2

1.53e-03200303M3316
CoexpressionGSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN

PRPF8 TIAM1 DSCAML1

1.53e-03200303M9382
CoexpressionGSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN

RESF1 TIAM1 EPAS1

1.53e-03200303M6247
CoexpressionGSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN

TRANK1 RBCK1 NDUFV2

1.53e-03200303M7595
CoexpressionGSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN

NDNF TIAM1 ZNF768

1.53e-03200303M9321
CoexpressionGSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN

TRANK1 RBCK1 NDUFV2

1.53e-03200303M3279
CoexpressionGSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP

PRPF8 SYNGR2 RBCK1

1.53e-03200303M7031
CoexpressionGSE21063_WT_VS_NFATC1_KO_BCELL_DN

UTP3 PRPF8 TOX2

1.53e-03200303M8261
CoexpressionGSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP

TIAM1 DTNA EPAS1

1.53e-03200303M3407
CoexpressionGSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP

FGFR2 UTP3 RBCK1

1.53e-03200303M5168
CoexpressionHALLMARK_GLYCOLYSIS

CD44 COL5A1 RBCK1

1.53e-03200303M5937
CoexpressionHALLMARK_MYOGENESIS

SORBS1 DTNA SYNGR2

1.53e-03200303M5909
CoexpressionHALLMARK_ESTROGEN_RESPONSE_LATE

CD44 TIAM1 ACOX2

1.53e-03200303M5907
CoexpressionGSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN

TRANK1 RBCK1 BACH1

1.53e-03200303M9586
CoexpressionGSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP

STRN TIAM1 ZNF768

1.53e-03200303M6535
CoexpressionGSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP

TRANK1 NABP1 TOX

1.53e-03200303M6524
CoexpressionGSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN

COL5A1 EPAS1 NDUFV2

1.53e-03200303M9623
CoexpressionGSE3982_BASOPHIL_VS_TH2_UP

TRANK1 ARHGEF10 EPAS1

1.53e-03200303M5566
CoexpressionGSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN

CD44 TRANK1 RESF1

1.53e-03200303M8620
CoexpressionGSE29618_MONOCYTE_VS_MDC_UP

CD44 TIAM1 BACH1

1.53e-03200303M4948
CoexpressionGSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN

UTP3 PRPF8 SYNGR2

1.53e-03200303M3646
CoexpressionGSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN

FGFR2 DTNA DSCAML1

1.53e-03200303M6791
CoexpressionGSE3982_DC_VS_TH2_UP

RESF1 ZNF768 ACOX2

1.53e-03200303M5484
CoexpressionGSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN

CD44 NABP1 PRPF8

1.53e-03200303M8531
CoexpressionGSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN

CD44 TIAM1 SYNGR2

1.53e-03200303M7208
CoexpressionGSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN

TOX TIAM1 TOX2

1.53e-03200303M9285
CoexpressionGSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN

CD44 NDNF TOX2

1.53e-03200303M9272
CoexpressionAtlasDevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000

CD44 COL5A1 TRANK1 NABP1 RESF1 DTNA DSCAML1 BACH1

1.24e-05814308gudmap_developingGonad_e18.5_testes_1000
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000

CD44 COL5A1 TRANK1 NABP1 RESF1 TOX DTNA BACH1

1.30e-05819308gudmap_developingGonad_P2_testes_1000
CoexpressionAtlasdev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_100

TRANK1 NABP1 DTNA

1.91e-0537303gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_100
CoexpressionAtlasDevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500

TRANK1 NABP1 RESF1 DTNA DSCAML1 BACH1

2.06e-05412306gudmap_developingGonad_e18.5_testes_500
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000

CD44 COL5A1 TRANK1 TOX DTNA

7.76e-05319305gudmap_developingGonad_P2_testes_1000_k4
CoexpressionAtlasdev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200

TRANK1 NABP1 TOX DTNA

9.24e-05170304gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_200
CoexpressionAtlasDevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000

COL5A1 TRANK1 NABP1 RESF1 DTNA DSCAML1 BACH1

1.16e-04819307gudmap_developingGonad_e16.5_testes_1000
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500

TRANK1 NABP1

1.26e-0412302gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_500
CoexpressionAtlasdev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_200

TRANK1 TOX DTNA

1.36e-0471303gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k1_200
CoexpressionAtlasdev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_100

TRANK1 NABP1 DTNA

2.09e-0482303gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_100
CoexpressionAtlasDevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#4_top-relative-expression-ranked_500

NABP1 RESF1 DSCAML1

2.32e-0485303gudmap_developingGonad_e16.5_testes_500_k4
CoexpressionAtlasdev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_100

TRANK1 NABP1 DTNA

2.58e-0488303gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_100
CoexpressionAtlasdev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500

TRANK1 NABP1 TOX TIAM1 DTNA

3.22e-04433305gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5

FGFR2 ANK2 TOX TOX2 IFT57 DTNA

5.20e-04743306Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5
CoexpressionAtlasDevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_1000

NABP1 RESF1 DSCAML1

5.79e-04116303gudmap_developingGonad_e18.5_testes_1000_k5
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500

FGFR2 NABP1 TOX2 DTNA EPAS1

5.94e-04495305Facebase_RNAseq_e8.5_Floor Plate_500
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_500

CD44 TRANK1 TOX

5.94e-04117303gudmap_developingGonad_P2_testes_500_k2
ToppCell5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 RESF1 TOX TIAM1 TOX2

1.31e-07181305a6c8b33a392de3df2f179317e329e45d3d8c6f52
ToppCell10x5'-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue

RESF1 TOX TIAM1 TOX2 DSCAML1

1.42e-0718430522c15ce30171c687ab564f4383ae74d38b759272
ToppCellIPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class

TOX TIAM1 TOX2 NDUFV2 BACH1

1.62e-071893057a260485c2a7c743c14d048e5e480ae0a9b8e32c
ToppCellCOPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class

TOX TIAM1 TOX2 NDUFV2 BACH1

1.71e-071913053ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CD44 COL5A1 NABP1 PLEKHH2 TOX2

1.71e-0719130508720998aa55131d7377c4c67c4c935865bd7d79
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue

CD44 TOX TIAM1 TOX2 NDUFV2

1.76e-0719230591a4d06e8d1d1fe2ce5f72668108513bd2a72c4d
ToppCellnormal_Lymph_Node-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass

NABP1 TOX TOX2 NDUFV2 BACH1

1.80e-0719330551fd629e91c85881c3231486d6d2fb2c65fcd77b
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass

NABP1 TOX2 SYNGR2 NDUFV2 BACH1

1.85e-07194305e46963d5f156526342ebc0fb9e767d266e812c42
ToppCellmLN-T_cell-Treg|T_cell / Region, Cell class and subclass

TOX TIAM1 TOX2 NDUFV2 BACH1

1.99e-071973053779489d57ebda33277c79cba037f4c73128c8ba
ToppCellT_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

CD44 NABP1 RESF1 TIAM1 TOX2

1.99e-07197305de5448fcdf4e433fc167496413abe5d0c8a5c6d8
ToppCell(1)_T_cell-(15)_Treg|(1)_T_cell / shred on Cell_type and subtype

TOX TIAM1 TOX2 NDUFV2 BACH1

1.99e-071973056e7723e8b977be35c60cc11ac7cfa4f71339441e
ToppCellmLN-(1)_T_cell-(15)_Treg|mLN / shred on region, Cell_type, and subtype

NABP1 TOX TIAM1 TOX2 NDUFV2

2.04e-07198305d4885f9c59b275e4e50dfcfb51c5351bebba1769
ToppCellmLN-T_cell-Treg|mLN / Region, Cell class and subclass

NABP1 TOX TIAM1 TOX2 NDUFV2

2.04e-071983056ce9681d1287632956176239f223e71abb8de44f
ToppCellCaecum-T_cell-Treg|T_cell / Region, Cell class and subclass

TOX TIAM1 TOX2 NDUFV2 BACH1

2.04e-0719830590a2a75ca078f7088b8739795a9b396113bcbe23
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor

SORBS1 ARHGEF10 TOX2 EPAS1

5.11e-06171304bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

SORBS1 ARHGEF10 TOX2 EPAS1

6.40e-06181304c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A1 FGFR2 PLEKHH2 DSCAML1

6.40e-061813046a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A1 FGFR2 PLEKHH2 DSCAML1

6.68e-06183304cfae90c309622b5d499e62a3a8a8b9746478d28d
ToppCell(1)_T_cells-(1)_T_regulatory|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

TOX TIAM1 EPAS1 BACH1

6.83e-061843043cbf81757653652441843d85cb7ec1dcf25ca1b0
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

CD44 SORBS1 DTNA DSCAML1

6.83e-06184304d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCellControl-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class

TOX TIAM1 TOX2 BACH1

6.98e-06185304e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor

DCHS1 SORBS1 TOX2 EPAS1

6.98e-0618530407f9f38f0739d7c830641723a38385550ac1ac92
ToppCellControl-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations)

SORBS1 ARHGEF10 TOX2 EPAS1

7.13e-06186304c6075fe84226b370c5139066793844ad33ae2db1
ToppCellControl-Endothelial_cells|Control / group, cell type (main and fine annotations)

SORBS1 ARHGEF10 TOX2 EPAS1

7.43e-061883043953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD44 COL5A1 SORBS1 NABP1

7.75e-061903041121eb607a984c59fbffe7220837fc178745aa55
ToppCellCOVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations)

SORBS1 ARHGEF10 TOX2 EPAS1

7.75e-06190304812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell(1)_T_cells-(1)_T_CD4_fh|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

NABP1 RESF1 TOX TOX2

7.75e-06190304120ca702600373c208a3d032fede0a040736e5cf
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD44 COL5A1 SORBS1 NABP1

7.75e-06190304048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellCOVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

SORBS1 ARHGEF10 TOX2 EPAS1

7.75e-061903049fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell(1)_T_CD4_fh|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

NABP1 RESF1 TOX TOX2

7.91e-0619130466ddff9a99092cb384b9fb2a3ba95ddbebed67cc
ToppCelltumor_Lung-T/NK_cells-Exhausted_Tfh|tumor_Lung / Location, Cell class and cell subclass

TOX TIAM1 TOX2 NDUFV2

7.91e-061913043e259eba83f8159d1a1a96b98d0e867fe547c5e7
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

COL5A1 PLEKHH2 ANK2 DTNA

7.91e-061913046688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

COL5A1 PLEKHH2 ANK2 DTNA

8.08e-0619230499ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A1 PLEKHH2 ANK2 DTNA

8.08e-061923043d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue

TOX TIAM1 TOX2 NDUFV2

8.08e-0619230404bd6e135733570e877af9460f87379ed0a5c5f8
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_TFH-like|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TOX TIAM1 TOX2 NDUFV2

8.08e-061923040f9cae41bb9bc9366efe9eb48e26b3e80c642879
ToppCellnormal_Lymph_Node-T/NK_cells-Treg|normal_Lymph_Node / Location, Cell class and cell subclass

NABP1 TOX TOX2 NDUFV2

8.08e-06192304d2c2a98d331522a3ab7973bfaf4396ef4d684888
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A1 PLEKHH2 ANK2 DTNA

8.08e-06192304deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SORBS1 ARHGEF10 TOX2 EPAS1

8.24e-06193304f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A1 PLEKHH2 ANK2 DTNA

8.24e-06193304fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SORBS1 ARHGEF10 TOX2 EPAS1

8.24e-06193304a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellCF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class

CD44 TOX IFT57 BACH1

8.24e-061933047ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A1 PLEKHH2 ANK2 DTNA

8.41e-0619430460622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FGFR2 NABP1 EPAS1 SYNGR2

8.41e-061943045da8873cddff582e5693b32fd3aaebc102f65fc0
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue

CD44 COL5A1 NABP1 EPAS1

8.41e-061943044547b57669be5d4f0de55175802ee04372288a6a
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A1 PLEKHH2 ANK2 DTNA

8.41e-061943046e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellILEUM-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TOX2 EPAS1 NDUFV2 BACH1

8.41e-061943040396457834bbfed8d0b9b2ddaaecd9f28e1d56ed
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL5A1 SORBS1 EPAS1 BACH1

8.41e-06194304e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A1 PLEKHH2 ANK2 DTNA

8.41e-0619430489b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Tfh|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RESF1 TOX TIAM1 TOX2

8.58e-06195304ea83c3c93ec4e09029185508bdbd6d9cc5e441d5
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

COL5A1 PLEKHH2 TOX2 DTNA

8.58e-0619530461c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

COL5A1 PLEKHH2 TOX2 DTNA

8.58e-06195304603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCelltumor_Lung-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass

TOX2 SYNGR2 NDUFV2 BACH1

8.58e-06195304dd112ef3f8bd0790719827b6bb120918687afdff
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Tfh|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RESF1 TOX TIAM1 TOX2

8.58e-06195304b2ecab35db438c82872cd16a6e9f013475e559ef
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

COL5A1 PLEKHH2 TOX2 DTNA

8.58e-06195304aa0add081881d349099d12efca5cdee098038d4e
ToppCellcritical-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

NABP1 RESF1 TIAM1 TOX2

8.76e-06196304861665912eb0538b083d3eee77190925b3a43c24
ToppCellnucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SORBS1 ARHGEF10 TOX2 EPAS1

8.76e-06196304686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCellIPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class

CD44 SORBS1 TOX2 EPAS1

8.76e-061963048f0f72ead06abe02b575e443552eacc2151077ef
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL5A1 NABP1 PLEKHH2 ANK2

8.94e-0619730494a9603cbd3516fbcce871909693b88f20d41713
ToppCellNS-critical-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD44 NABP1 RESF1 BACH1

8.94e-06197304f38037dfa6c33e9336130d0cc65eaba0f120efb9
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

COL5A1 PLEKHH2 ANK2 DTNA

9.12e-06198304df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellNS-critical-d_07-13-Myeloid|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD44 NABP1 RESF1 BACH1

9.12e-0619830408bc3f63a5c5b65bff10aadebdaa5e7f192cda01
ToppCellcritical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD44 NABP1 RESF1 BACH1

9.12e-061983044da73dc3acb29d70b160903600d2bf7fdab34333
ToppCellCaecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype

RESF1 TOX TIAM1 TOX2

9.30e-0619930412c22b07a231c9dc548e9dc37e0a60296a4a6273
ToppCellNS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD44 FGFR2 EPAS1 SYNGR2

9.30e-0619930432bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCellILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

COL5A1 FGFR2 PLEKHH2 ANK2

9.30e-061993043a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCellCaecum-T_cell-Treg|Caecum / Region, Cell class and subclass

RESF1 TOX TIAM1 TOX2

9.30e-06199304ab0b32c077ac26d32a293dcf686af6984980793f
ToppCellcritical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD44 NABP1 RESF1 BACH1

9.30e-0619930416c55cb8a0e740342009965f0eddfb0ed2858fab
ToppCellcontrol-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD44 FGFR2 EPAS1 SYNGR2

9.30e-061993043d01f90ffd271ca00129192787e4921bdca7e01e
ToppCellcontrol-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD44 FGFR2 EPAS1 SYNGR2

9.30e-06199304262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RESF1 ARHGEF10 TOX2 EPAS1

9.49e-06200304b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCellLPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

SORBS1 ARHGEF10 TOX2 EPAS1

9.49e-062003047034f57e282982c19c13ee8ab78eabaffa069e30
ToppCellTracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SORBS1 TOX TIAM1 DSCAML1

9.49e-06200304b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

RESF1 ARHGEF10 TOX2 EPAS1

9.49e-06200304bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

COL5A1 PLEKHH2 TOX2 DTNA

9.49e-06200304e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type

RESF1 ARHGEF10 TOX2 EPAS1

9.49e-06200304432384faeade8e609154fab3d96c955a8ec868dd
ToppCellTracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SORBS1 TOX TIAM1 DSCAML1

9.49e-06200304f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCellLPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

RESF1 ARHGEF10 TOX2 EPAS1

9.49e-0620030479e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

RESF1 ARHGEF10 TOX2 EPAS1

9.49e-0620030466f7e8ee63c828f17468e79a4b816346b33e8980
ToppCellfrontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FGFR2 ARHGEF10 SYNGR2

1.06e-04137303b03f19b233c1c809f2cd2b4a7642eeaf254a6289
ToppCellfacs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NABP1 ZNF768 BRWD3

1.06e-04137303e9b88ad86b75454a8292a94879c5b665adc42744
ToppCellprimary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype

COL5A1 SORBS1 TIAM1

1.15e-04141303605d7b28e99c943f64b4095855a6f9f70e92cb09
ToppCellmild_COVID-19_(asymptomatic)-Treg|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

TOX TOX2 NABP2

1.25e-041453032d0903009e918500facfd017ff31f2cec1e76131
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PLEKHH2 DTNA BRWD3

1.27e-04146303cffa91d76606f74553d81150adbb23b003746316
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

PLEKHH2 DTNA BRWD3

1.46e-04153303e7d20c88466ff81db613869cf7a6a4bb95fd6c2f
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NDNF TOX2 DSCAML1

1.58e-04157303516903469756c5fabfdf56d7bd59b3bdd7b44e39
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PLEKHH2 DTNA ACOX2

1.64e-041593037cda111bb98f1241989e49d490bdf51a712ea589
ToppCellControl-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations)

SORBS1 TOX2 EPAS1

1.67e-04160303958256e3d3836160763b82bb48f794087918d935
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

NABP1 PLEKHH2 TOX

1.67e-041603030293b244c063a62819690bf22bbc2681f8d15252
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLEKHH2 DTNA DSCAML1

1.67e-04160303c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

NABP1 PLEKHH2 TOX

1.67e-041603033eaae86fa08f7651021316f8e5811bf48055591e
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLEKHH2 DTNA DSCAML1

1.67e-0416030325c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellAT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

NDNF COL5A1 ANK2

1.73e-0416230357d627259d27f39885bf416d74bcb6656db6e27b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SORBS1 UTP3 DTNA

1.76e-04163303ce07bc424ef99c547588b07f5c8b39ff0773ca9b
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NDNF TOX2 DSCAML1

1.76e-041633038d17f44faf0549fe71a9a45f811f50d767275414
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SORBS1 FGFR2 ARHGEF10

1.76e-041633036c4d4c55fc8a731acca13c1ba7287f238a9d81e0
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NDNF TOX2 DSCAML1

1.80e-0416430308819970174a3eb4eee8e1e675075828665b845e
ToppCellAdult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor

DCHS1 COL5A1 PLEKHH2

1.80e-041643033d8ff70fe5582d1fb56b338be8b76fa1428b3657
ToppCellNS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD44 DCHS1 SORBS1

1.80e-0416430335c673380f75cb4bfe080089bc723c4373bcc7a5
ToppCellT_cells-TFH-like_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

TOX TIAM1 TOX2

1.80e-04164303b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5
DrugTrichlormethiazide [133-67-5]; Down 200; 10.6uM; PC3; HT_HG-U133A

COL5A1 FGFR2 TIAM1 ARHGEF10 EPAS1

5.24e-061953054198_DN
DrugGuanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A

SORBS1 NABP1 ANK2 TOX DTNA

5.37e-061963053171_UP
DrugSertaconazole nitrate [99592-39-9]; Up 200; 8uM; PC3; HT_HG-U133A

COL5A1 SORBS1 FGFR2 TOX DTNA

5.51e-061973054475_UP
DrugTodralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A

STRN SORBS1 FGFR2 ARHGEF10 DTNA

5.65e-061983055087_UP
Drugthioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

CD44 FGFR2 TIAM1 EPAS1

4.93e-051553041068_UP
Drug15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A

CD44 COL5A1 STRN DTNA

9.20e-051823046990_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

CD44 STRN FGFR2 DTNA

9.40e-051833046985_UP
DrugDobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A

TRANK1 TIAM1 ZNF768 EPAS1

9.80e-051853046286_UP
DrugProgesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A

STRN TRANK1 ARHGEF10 DTNA

1.00e-041863042426_DN
Drug(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A

COL5A1 TRANK1 ANK2 ARHGEF10

1.04e-041883043046_UP
DrugSanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A

CD44 COL5A1 STRN BACH1

1.11e-041913044168_DN
DrugDeptropine citrate [2169-75-7]; Up 200; 7.6uM; PC3; HT_HG-U133A

SORBS1 FGFR2 DTNA ZNF768

1.13e-041923045118_UP
DrugPramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A

COL5A1 TIAM1 DTNA RBCK1

1.13e-041923046054_DN
Drugestradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A

COL5A1 STRN FGFR2 DTNA

1.13e-041923045955_UP
DrugProbenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A

CD44 FGFR2 ZNF768 NABP2

1.15e-041933042825_DN
DrugParbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A

TOX TIAM1 DTNA EPAS1

1.15e-041933043799_DN
DrugGlycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A

TIAM1 ARHGEF10 ZNF768 NABP2

1.18e-041943045316_DN
DrugNifedipine [21829-25-4]; Up 200; 11.6uM; PC3; HT_HG-U133A

COL5A1 SORBS1 NABP1 ZNF768

1.18e-041943047303_UP
DrugChloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A

TOX ZNF768 EPAS1 BACH1

1.18e-041943045047_DN
DrugS(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A

SORBS1 TIAM1 ARHGEF10 DTNA

1.20e-041953046299_UP
DrugMexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; HL60; HT_HG-U133A

CD44 FGFR2 ARHGEF10 ZNF768

1.20e-041953042364_UP
DrugOxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

STRN FGFR2 ARHGEF10 ZNF768

1.20e-041953046770_DN
DrugBisoprolol fumarate; Down 200; 9uM; PC3; HT_HG-U133A

SORBS1 TOX EPAS1 NABP2

1.22e-041963046748_DN
DrugProcainamide hydrochloride [614-39-1]; Up 200; 14.8uM; PC3; HT_HG-U133A

STRN FGFR2 TOX ARHGEF10

1.22e-041963044602_UP
DrugTrimipramine maleate salt [521-78-8]; Down 200; 9.8uM; PC3; HT_HG-U133A

COL5A1 TOX TIAM1 ZNF768

1.22e-041963044083_DN
DrugCefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; HL60; HT_HG-U133A

STRN TOX ZNF768 EPAS1

1.22e-041963042988_UP
DrugBupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; PC3; HT_HG-U133A

COL5A1 STRN SORBS1 DTNA

1.22e-041963045112_UP
DrugDimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A

STRN NABP1 EPAS1 NABP2

1.22e-041963043029_DN
DrugRapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A

FGFR2 ARHGEF10 NABP2 BACH1

1.22e-041963042667_DN
DrugFuraltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A

STRN FGFR2 DTNA RBCK1

1.25e-041973043838_DN
DrugDimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A

FGFR2 TIAM1 DTNA EPAS1

1.25e-041973044207_DN
DrugSerotonin hydrochloride [153-98-0]; Down 200; 18.8uM; PC3; HT_HG-U133A

COL5A1 TIAM1 ARHGEF10 DTNA

1.25e-041973044673_DN
DrugCP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A

COL5A1 TOX DTNA ZNF768

1.25e-041973044557_DN
DrugSulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A

CD44 DTNA ZNF768 EPAS1

1.25e-041973042814_DN
DrugLactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

ANK2 ARHGEF10 EPAS1 BACH1

1.25e-041973046605_UP
DrugClonidine hydrochloride [4205-91-8]; Up 200; 15uM; PC3; HT_HG-U133A

COL5A1 FGFR2 ANK2 ARHGEF10

1.25e-041973044478_UP
DrugPropranolol hydrochloride [318-98-9]; Up 200; 13.6uM; PC3; HT_HG-U133A

COL5A1 TRANK1 DTNA ZNF768

1.25e-041973046759_UP
DrugCyclopenthiazide [742-20-1]; Up 200; 10.6uM; HL60; HT_HG-U133A

NDNF NABP1 DTNA ACOX2

1.27e-041983042905_UP
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A

CD44 SORBS1 DTNA RBCK1

1.27e-041983046976_UP
DrugLymecycline [992-21-2]; Up 200; 6.6uM; PC3; HT_HG-U133A

NABP1 TOX TIAM1 ZNF768

1.27e-041983047291_UP
DrugTriamterene [396-01-0]; Up 200; 15.8uM; PC3; HT_HG-U133A

SORBS1 TRANK1 TIAM1 EPAS1

1.27e-041983047307_UP
DrugBemegride [64-65-3]; Down 200; 25.8uM; HL60; HT_HG-U133A

FGFR2 ZNF768 EPAS1 ACOX2

1.27e-041983043051_DN
DrugSulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A

COL5A1 TOX TIAM1 DTNA

1.27e-041983044661_DN
DrugRilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; PC3; HT_HG-U133A

NDNF SORBS1 DTNA ZNF768

1.27e-041983045107_UP
DrugReserpine [50-55-5]; Down 200; 6.6uM; PC3; HT_HG-U133A

FGFR2 TIAM1 DTNA EPAS1

1.27e-041983044203_DN
DrugBumetanide [28395-03-1]; Up 200; 11uM; PC3; HT_HG-U133A

STRN SORBS1 DTNA ZNF768

1.27e-041983045117_UP
DrugCisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A

CD44 FGFR2 TIAM1 NABP2

1.27e-041983043305_DN
DrugSpectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; PC3; HT_HG-U133A

FGFR2 TIAM1 DTNA EPAS1

1.27e-041983044187_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A

STRN SORBS1 DTNA ZNF768

1.27e-041983043707_DN
DrugHeptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A

NABP1 TIAM1 ARHGEF10 DTNA

1.27e-041983047313_UP
DrugParoxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A

CD44 SORBS1 DTNA ACOX2

1.27e-041983044378_UP
DrugMeclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A

CD44 NDNF TIAM1 DTNA

1.30e-041993043707_UP
DrugTropine [120-29-6]; Up 200; 28.4uM; PC3; HT_HG-U133A

COL5A1 FGFR2 ARHGEF10 DTNA

1.30e-041993045790_UP
DrugC75; Up 200; 10uM; MCF7; HT_HG-U133A

STRN SORBS1 TRANK1 BACH1

1.30e-041993046394_UP
DrugClozapine [5786-21-0]; Down 200; 12.2uM; PC3; HT_HG-U133A

COL5A1 FGFR2 NABP1 DTNA

1.30e-041993044670_DN
DrugSulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A

SORBS1 FGFR2 ARHGEF10 BACH1

1.30e-041993044389_UP
DrugLobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; PC3; HT_HG-U133A

SORBS1 NABP1 TOX ZNF768

1.30e-041993045784_DN
DrugAustricine [10180-88-8]; Down 200; 14.2uM; PC3; HT_HG-U133A

FGFR2 TIAM1 ARHGEF10 EPAS1

1.32e-042003044213_DN
DrugLoperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HT_HG-U133A

COL5A1 STRN FGFR2 TIAM1

1.32e-042003044672_DN
Drugmethylselenic acid

CD44 SORBS1 ANK2 DTNA BACH1

1.86e-04412305ctd:C008493
Drugdibromoacetic acid

TOX ACOX2

2.83e-0419302CID000012433
DrugMethylcholanthrene

CD44 COL5A1 FGFR2 ANK2 DTNA EPAS1 ACOX2

3.17e-041034307ctd:D008748
Drugmercuric bromide

CD44 FGFR2 NABP1 TOX IFT57 DTNA EPAS1

4.04e-041076307ctd:C042720
Drugpyrachlostrobin

COL5A1 FGFR2 PLEKHH2 ARHGEF10 EPAS1 SYNGR2

5.72e-04811306ctd:C513428
Drug1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine

NDNF EPAS1

9.17e-0434302ctd:C000591541
DrugAsbestos, Crocidolite

CD44 COL5A1 FGFR2 NABP1 EPAS1 RBCK1 BACH1

9.46e-041241307ctd:D017638
DrugSb-H

CD44 PRPF8

1.03e-0336302CID005289334
DrugAC1L98DX

TOX TOX2

1.15e-0338302CID000439957
DrugON 01910

CD44 FGFR2 BACH1

1.25e-03162303ctd:C507134
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

CD44 DTNA ZNF768

1.48e-031723031017_UP
DrugParthenolide [20554-84-1]; Up 200; 16.2uM; PC3; HT_HG-U133A

SORBS1 FGFR2 BACH1

1.51e-031733035105_UP
DrugChloroprene

NDNF COL5A1 SORBS1 TIAM1 TOX2 DTNA ACOX2

1.53e-031348307ctd:D002737
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

SORBS1 FGFR2 ARHGEF10

1.63e-031783034483_UP
DrugAlexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A

CD44 FGFR2 BACH1

1.66e-031793034721_UP
DrugCephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; MCF7; HT_HG-U133A

CD44 STRN TIAM1

1.69e-031803033290_DN
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

SORBS1 TRANK1 EPAS1

1.71e-031813033688_UP
DrugSTOCK1N-35696; Up 200; 15uM; MCF7; HT_HG-U133A

COL5A1 STRN DTNA

1.74e-031823036577_UP
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

FGFR2 ANK2 ARHGEF10

1.77e-031833032696_DN
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

FGFR2 TIAM1 EPAS1

1.80e-031843032686_UP
DrugCP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A

ARHGEF10 DTNA ACOX2

1.85e-031863034380_UP
Drug0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A

CD44 STRN DTNA

1.85e-031863036900_UP
Drug0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A

STRN DTNA ZNF768

1.88e-031873036902_UP
DrugMethotrexate [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A

CD44 COL5A1 DTNA

1.88e-031873035419_UP
Drugtroglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA

CD44 FGFR2 EPAS1

1.88e-031873031070_UP
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

CD44 STRN DTNA

1.88e-031873036984_UP
Drugikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA

COL5A1 STRN DTNA

1.91e-03188303974_UP
DrugNaftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; HL60; HT_HG-U133A

UTP3 DTNA NABP2

1.94e-031893032911_DN
DrugChlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A

SORBS1 TIAM1 EPAS1

1.94e-031893033788_DN
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

SORBS1 FGFR2 BACH1

1.94e-031893035586_UP
Diseasebanks of the superior temporal sulcus volume measurement

FGFR2 TOX

1.35e-0417302EFO_0010286
Diseasenose morphology measurement

SORBS1 RESF1 DSCAML1 EPAS1

3.31e-04329304EFO_0007843
Diseaseretinitis pigmentosa (implicated_via_orthology)

FGFR2 PRPF8

3.45e-0427302DOID:10584 (implicated_via_orthology)
Diseaseessential tremor

TOX DSCAML1 NDUFV2

3.55e-04136303EFO_0003108
Diseaseprostate cancer (implicated_via_orthology)

FGFR2 PRPF8

5.17e-0433302DOID:10283 (implicated_via_orthology)
Diseasecolorectal adenocarcinoma (is_implicated_in)

CD44 FGFR2

5.82e-0435302DOID:0050861 (is_implicated_in)
Diseaseheart failure

STRN EPAS1 BACH1

8.69e-04185303EFO_0003144
Diseaseadipose tissue measurement

SORBS1 ARHGEF10

9.63e-0445302EFO_0004764
DiseaseQRS complex, QRS duration

STRN EPAS1

9.63e-0445302EFO_0005054, EFO_0005055
DiseaseAcute Promyelocytic Leukemia

CD44 NABP1

1.01e-0346302C0023487

Protein segments in the cluster

PeptideGeneStartEntry
TPNSPEDYYTSLDND

EPAS1

481

Q99814
SPTNTQENPAYEEYI

ACOX2

656

Q99424
DDYVSEPQQEPCPYA

BACH1

481

O14867
YNPEPYLNNESQPDS

ARHGEF10

901

O15013
TVESQQPFQPEYPDS

BRWD3

1066

Q6RI45
NDEIYDPQITSPYEN

ANK2

2916

Q01484
DLSQPLEQYSPSYPD

FGFR2

771

P21802
SDENDNPPQFYPREY

DCHS1

676

Q96JQ0
PEAYQVPASYQPDEE

RBCK1

221

Q9BYM8
VYATTTPESDQPYPE

NDNF

161

Q8TB73
PPDAYSTDTEYSQPE

PLEKHH2

671

Q8IVE3
PFEQPQEYDDPNATI

IFT57

101

Q9NWB7
YRTNPEDIYPSNPTD

CD44

161

P16070
PAPSEYETSPEQLFY

DSCAML1

1236

Q8TD84
YVYPDPTQEETYPSN

CENPJ

221

Q9HC77
TPQSQDPNPDEYYTE

COL5A1

251

P20908
PYVQPEDENYENDSV

DTNA

701

Q9Y4J8
PSPGDTSYYQDQVDD

UTP3

36

Q9NQZ2
TNPNIDPYDSYDPSV

STRN

546

O43815
YSEVPNFSEPNPDYR

NABP1

106

Q96AH0
YPQEIDASSNYTPQD

RESF1

1021

Q9HCM1
SEPTEPYLSSQNYGE

PRPF8

1756

Q6P2Q9
AAEETPPYSNYNTLP

TIAM1

276

Q13009
VYSEVPNFSEPNPEY

NABP2

101

Q9BQ15
SEEDNPYTPTYQFPA

SORBS1

431

Q9BX66
SPEFESQSPRYEPQS

ZNF768

111

Q9H5H4
DFIQNYVDPTPDPNT

SYNGR2

176

O43760
YNGQSENNEDYEIPP

TOX2

66

Q96NM4
NPEYFPPASAVETEY

TRANK1

966

O15050
EPSQDYVPASQSYPG

TOX

46

O94900
ENNPDTPFDFTPENY

NDUFV2

46

P19404